Melanoma Header
opdivo-dtc-util-nav

Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user and his son walking and embracing.
Potential OPDIVO® (nivolumab) user and his son walking and embracing.

Clinical trial results
for melanoma

See results for OPDIVO immunotherapy, alone or in combination with YERVOY

Actor portrayals.
OPDIVO is not approved for people
younger than 12 years of age.

Advanced melanoma

OPDIVO + YERVOY

For adults and children 12 years of age and older with previously untreated advanced melanoma

Advanced melanoma

OPDIVO

For adults and children 12 years of age and older with previously untreated advanced melanoma

Stage 2B or Stage 2C melanoma after surgery

OPDIVO

For adults and children 12 years and older to help prevent melanoma from coming back after it has been completely removed by surgery

Stage 3B/C or Stage 4 melanoma after surgery

OPDIVO

For adults and children 12 years and older to help prevent melanoma from coming back after it has been completely removed by surgery

OPDIVO and OPDIVO + YERVOY will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion